Navigation Links
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
Date:2/7/2008

Application to be reviewed under European Accelerated Assessment Procedure

BOULDER, Colo., Feb. 7 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced that the European Medicines Agency (EMEA) has accepted for review the Company's Marketing Authorization Application (MAA) for Vidaza(R) (azacitidine for injection) in patients with higher-risk myelodysplastic syndromes (MDS) and announced its intent to review the application under the Accelerated Assessment Procedure. Pharmion submitted the Vidaza MAA to the EMEA earlier this month.

The Accelerated Assessment Procedure is granted for medicinal products that are expected to be of major public health interest, particularly from the point of view of therapeutic innovation. Accelerated Assessment reduces the time limit for the Committee for Medicinal Products for Human Use (CHMP) to give an opinion from 210 days to 150 days. At any time during the marketing authorization application evaluation, the CHMP may decide to continue the assessment under standard centralized procedure timelines.

The application is based upon clinical data which include the results from the Company's Phase 3 multi-center, international, randomized study of Vidaza(R) (azacitidine for injection) in the treatment of patients with higher-risk MDS. The primary objective of this Phase 3 trial was to demonstrate superiority in overall survival of Vidaza versus conventional care regimens, and these data were presented at the American Society of Hematology annual meeting in December 2007.

Vidaza has been designated as an Orphan Medicinal Product in the EU for the treatment of MDS, which, if approved, entitles the drug to ten years of market exclusivity for the approved indication
'/>"/>

SOURCE Pharmion Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. FDA Accepts Ranexa(R) sNDA and NDA for Filing
2. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
3. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
4. FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
5. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
6. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
9. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q1/08 Review Issued By Scimitar Equity Research, Inc.
11. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...., Nov. 25 Research Triangle Park-...ent, single-treatment water purification system Na...ra Pradesh, Minister of Rural Water Supply, Hon. M...ndia today. Initial tests, performed at Indian Ins...the majority of the drinking water available in In...
(Date:11/25/2009)...assador to Speak at Economic Club of Canada , ...ber 25, 2009 -- Ambassador to Speak at Economic Cl...mbassador for International Investment, and Chairm... a biography of David Appia go to www.investinfra...le to meet with press to discuss recent pro-busine...
(Date:11/25/2009)... 25 /PRNewswire/ - Cytochroma today announced the ...rectors. Dr. Moldt will replace Mr. Ulrik Spork as...d. The number of Board members remains unchanged a...me Peter Moldt to the board and look forward to be...hroma continues to make progress in becoming a lea...
(Date:11/25/2009)...ov. 25 Reportlinker.com announces ...its catalogue: ,, Brazil Bioethanol Market Ana...ortlinker.com/p0165503/Brazil-Bioethanol-Market-An...oethanol Market Analysis and Forecasts to 2013 ,...alysis and forecasts of the global bioethanol mark...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...esearchers at MIT and Texas Instruments have unvei...t can be up to 10 times more energy-efficient than... phones, implantable medical devices and sensors t... The innovative design will be presented Feb. 5 a...e in San Francisco by Joyce Kwong, a graduate stud...
...Side Branch Stent obtains CE Mark approval based o...n-Man Study) with No Side-Branch R... Tryton Medical, Inc., the leading,developer of st...tion,lesions announced that the company has receiv... Tryton Side-Branch Stent is a high performance,co...
...b. 4 Rochester Medical,Corporation (Nasdaq: ROCM...,quarter ending December 31, 2007., The Company r...r,compared to $7,512,000 for the first quarter of ... or $.02 per diluted share compared to a net incom...e first quarter of last,year. Net income for the f...
Other Biology Technology:Team develops energy-efficient microchip 2Tryton Medical Receives CE Mark Approval for its Side-Branch Stent 2Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 2Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 3Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 4Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 5Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 6Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter 7
(Date:11/25/2009)..., Head of the Cell Death Research Laboratory in th... been awarded the prestigious Johnson & Johnson Fo... cause of brain cell damage in Parkinson,s disease...sts in support of innovation and excellence in sci...red earlier this month at an event at the Hyatt Re...
(Date:11/24/2009)...ars it has been prescribed by traditional healers ...hes and stomach pain to fever and flu. , Now for ...y have been able to scientifically prove the pain ...e known as Brazilian mint. , Testing this ancient...archer Graciela Rocha was able to show that when p...
(Date:11/24/2009)...tion of a remarkable class of ring-shaped protein ...Lawrence Berkeley National Laboratory (Berkeley La...y beamline at the Advanced Light Source (ALS). The...ssion and replication, and are vital to the surviv...agents, such as the human papillomavirus, which ha...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 1ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 6448 3Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 1Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 2Medelita Introduces Men 26apos 3Bs Lab Coat Collection 61875 3MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 1MINDlink Foundation Launches to Connect the Cerebellum to Cures 61870 2
...merhaven, March 24th 2009. The research aircraft P... will start on Monday March 30th at 10 o,clock fro...asurement campaign which will last about four week...ic variables in an area between Spitsbergen, Green... of the project PAM-ARCMIP (Pan-Arctic Measurement...
... research published by a Queen,s University Belfas...in but that they retain a memory of it. , The stu...to small electric shocks, was carried out by Profe...f Biological Sciences at Queen,s and has been publ...sor Elwood, who previously carried out a study sho...
...cksburg, Va. Researchers have unveiled the evolut...ctures found in three species of Agrobacterium. A ...ence information with the genome sequences of othe... chromosomes are formed in bacteria.* , Agrobacte...also includes the benign, nitrogen-fixing organism...
Other Biology News:Research plane Polar 5 on Arctic campaign 2Crabs' memory of pain confirmed by Queen's academic 2Evolutionary origin of bacterial chromosomes revealed 2
...reedom EVOlyzer is Tecans new Enzyme-Linked Immuno...mated microplate processing. Freedom EVOlyzer is a...ng and includes state-of-the art reader, washer an...ed EVOlyzer software. The Freedom EVOlyzer is avai...
...ins are polypeptide hormones which belong to the t... TGF- superfamily is a large group of extra-cellul...velopment, reproductive function and tumor formati...etic proteins, growth differentiation factors, AMH...
...read Plating Beads Sterile plating in just secon...rdous ethanol flaming, More uniform spreading and...le packaging: dispenser bottle for spreading 100 p...t and easiest way to spread cells on multiple plat...
...aboratories working in a regulated environment, Pi...software that automates gravimetric pipette calibr...eets todays regulatory compliance requirements. Pi...es a full security implementation, support for Ora...
Biology Products: